Drugs & Targets European Commission approves Libtayo for advanced cutaneous squamous cell carcinoma July 05, 2019Vol.45 No.27
Drugs & Targets FDA approves Darzalex + lenalidomide and dexamethasone in multiple myeloma patients ineligible for transplant June 28, 2019Vol.45 No.26
Drugs & Targets European Commission approves Trecondi for hematopoietic stem cell transplantation June 28, 2019Vol.45 No.26
Drugs & Targets Intensity Therapeutics, Merck partner to evaluate INT230-6 and Keytruda June 28, 2019Vol.45 No.26
Drugs & Targets Development collaboration will focus on CAR-T cell therapy for breast cancer June 28, 2019Vol.45 No.26
